全文获取类型
收费全文 | 2526篇 |
免费 | 400篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 105篇 |
妇产科学 | 26篇 |
基础医学 | 532篇 |
口腔科学 | 105篇 |
临床医学 | 361篇 |
内科学 | 595篇 |
皮肤病学 | 63篇 |
神经病学 | 63篇 |
特种医学 | 37篇 |
外科学 | 263篇 |
综合类 | 315篇 |
预防医学 | 45篇 |
眼科学 | 22篇 |
药学 | 248篇 |
中国医学 | 50篇 |
肿瘤学 | 162篇 |
出版年
2024年 | 15篇 |
2023年 | 66篇 |
2022年 | 94篇 |
2021年 | 162篇 |
2020年 | 128篇 |
2019年 | 144篇 |
2018年 | 119篇 |
2017年 | 135篇 |
2016年 | 133篇 |
2015年 | 116篇 |
2014年 | 150篇 |
2013年 | 174篇 |
2012年 | 107篇 |
2011年 | 111篇 |
2010年 | 91篇 |
2009年 | 71篇 |
2008年 | 91篇 |
2007年 | 88篇 |
2006年 | 71篇 |
2005年 | 90篇 |
2004年 | 95篇 |
2003年 | 78篇 |
2002年 | 63篇 |
2001年 | 67篇 |
2000年 | 67篇 |
1999年 | 56篇 |
1998年 | 64篇 |
1997年 | 49篇 |
1996年 | 42篇 |
1995年 | 31篇 |
1994年 | 27篇 |
1993年 | 36篇 |
1992年 | 22篇 |
1991年 | 23篇 |
1990年 | 13篇 |
1989年 | 14篇 |
1988年 | 19篇 |
1987年 | 8篇 |
1986年 | 12篇 |
1985年 | 10篇 |
1984年 | 11篇 |
1983年 | 5篇 |
1982年 | 7篇 |
1981年 | 7篇 |
1980年 | 10篇 |
1979年 | 6篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1972年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有3007条查询结果,搜索用时 281 毫秒
51.
《Expert opinion on therapeutic patents》2013,23(10):1507-1510
Novel derivatives of 6-amino-2-benzylthio-4-hydroxypyrimidine are claimed as CXCR2 chemokine receptor antagonists useful in the treatment of chronic obstructive pulmonary disease, asthma and allergic rhinitis, inflammatory bowel disease, psoriasis, osteoarthritis, rheumatoid arthritis and cancer. The claimed compounds are monocylic analogues of previously described purine derivatives, at least some of which display reasonable affinity for the CXCR2 receptor. 相似文献
52.
53.
Stephanie M. Bozonet Anitra C. Carr Juliet M. Pullar Margreet C. M. Vissers 《Nutrients》2015,7(4):2574-2588
Neutrophils are the body’s primary defenders against invading pathogens. These cells migrate to loci of infection where they engulf micro-organisms and subject them to an array of reactive oxygen species and antimicrobial proteins to effect killing. Spent neutrophils subsequently undergo apoptosis and are cleared by macrophages, thereby resolving the inflammatory episode. Neutrophils contain high concentrations of vitamin C (ascorbate) and this is thought to be essential for their function. This may be one mechanism whereby vitamin C enhances immune function. The aim of our study was to assess the effect of dietary supplementation with vitamin C-rich SunGold kiwifruit on four important functions of neutrophils: chemotaxis, oxidant generation, extracellular trap formation, and apoptosis. Fourteen young men (aged 18–30 years) with suboptimal plasma vitamin C status (<50 μmol/L) were supplemented for four weeks with two SunGold kiwifruit/day. Plasma vitamin C status was monitored weekly and neutrophil vitamin C levels were assessed at baseline and post-intervention. Neutrophil function assays were carried out on cells isolated at baseline and post-intervention. Plasma vitamin C levels increased to >70 μmol/L (p < 0.001) within one week of supplementation and there was a significant increase in neutrophil vitamin C status following four weeks’ intervention (p = 0.016). We observed a significant 20% increase in neutrophil chemotaxis post-intervention (p = 0.041) and also a comparable increase in oxidant generation (p = 0.031). Supplementation did not affect neutrophil extracellular trap formation or spontaneous apoptosis. Our data indicate that supplementation with vitamin C-rich kiwifruit is associated with improvement of important neutrophil functions, which would be expected to translate into enhanced immunity. 相似文献
54.
Abderrahman Chargui Michèle Véronique El May 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2014,122(11):1047-1058
Neutrophils constitute the first line of cellular defense against pathogens and autophagy is a fundamental cellular homeostasis pathway that operates with the intracellular degradation/recycling system. Induction of the autophagic process in neutrophils, in response to invading pathogens, constitutes a crucial mechanism in innate immunity. Exploration of autophagy has greatly progressed and diverse strategies have been reported for studying this molecular process in different biological systems; especially in infectious and inflammatory diseases. Furthermore, the role of autophagy in neutrophils, during pathogenic infection, continues to be of interest, due to the role of the cell in immunity function, its recruitment to the site of infection and its implication in inflammatory diseases. This review focuses on the known role of autophagy in neutrophils defence against pathogenic infections. A more detailed discussion will concern the recent findings highlighting the role of autophagy in inflammation and cell death in infected neutrophils. 相似文献
55.
Amanda H. Anderson Dawei Xie Xue Wang Robin L. Baudier Paula Orlandi Lawrence J. Appel Laura M. Dember Jiang He John W. Kusek James P. Lash Sankar D. Navaneethan Akinlolu Ojo Mahboob Rahman Jason Roy Julia J. Scialla James H. Sondheimer Susan P. Steigerwalt F. Perry Wilson Raymond R. Townsend 《American journal of kidney diseases》2021,77(1):56-73.e1
56.
57.
58.
59.
60.
Qi Qiao Xiong Liu Ting Yang Kexin Cui Li Kong Conglian Yang Zhiping Zhang 《药学学报(英文版)》2021,11(10):3060-3091
Acute respiratory distress syndrome (ARDS) is characterized by the severe inflammation and destruction of the lung air–blood barrier, leading to irreversible and substantial respiratory function damage. Patients with coronavirus disease 2019 (COVID-19) have been encountered with a high risk of ARDS, underscoring the urgency for exploiting effective therapy. However, proper medications for ARDS are still lacking due to poor pharmacokinetics, non-specific side effects, inability to surmount pulmonary barrier, and inadequate management of heterogeneity. The increased lung permeability in the pathological environment of ARDS may contribute to nanoparticle-mediated passive targeting delivery. Nanomedicine has demonstrated unique advantages in solving the dilemma of ARDS drug therapy, which can address the shortcomings and limitations of traditional anti-inflammatory or antioxidant drug treatment. Through passive, active, or physicochemical targeting, nanocarriers can interact with lung epithelium/endothelium and inflammatory cells to reverse abnormal changes and restore homeostasis of the pulmonary environment, thereby showing good therapeutic activity and reduced toxicity. This article reviews the latest applications of nanomedicine in pre-clinical ARDS therapy, highlights the strategies for targeted treatment of lung inflammation, presents the innovative drug delivery systems, and provides inspiration for strengthening the therapeutic effect of nanomedicine-based treatment. 相似文献